Oruka Therapeutics COO Executes Planned Stock Transactions Amid Clinical Developments
Oruka Therapeutics, Inc. (NASDAQ:ORKA) recently saw insider activity from its Chief Operating Officer, Laura Lee Sandler. According to SEC filings, Sandler engaged in a series of transactions on May 1, 2026, involving the company's common stock. These movements included both the acquisition of shares through warrant exercises and the subsequent sal…